Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (1797)	4/26/1999 10:54:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Rick, The interesting news of the day: biz.yahoo.com Not much reaction out there. The info doesn't say very much, except how did ORG manage to have such a good heal rate in the hard to heal ulcers using current gold standard approaches...raises the question of what the severity level of the ulcers was. Also, the techvest report reminder today came out, simply touting their picks and their performances, including ATIS. Also, over the last few days, for those who haven't seen, Forbes (5/3) has a bit story about tissue engineering, primarily about cartilage, with a big blurb about ATIS, and the earlier part of the article primarily focusing on GZTC's carticel, including its plusses and minuses. Happy almost Tuesday. Marshall